Quantitative Investment Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Quantitative Investment Management’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-22,175	Closed	-$285K	–	472
2021 Q2	$285K	Buy	+22,175	New	+$254K	0.03%	336
2021 Q1	–	Sell	-46,255	Closed	-$526K	–	584
2020 Q4	$526K	Buy	+46,255	New	+$506K	0.04%	328
2019 Q2	–	Sell	-60,655	Closed	-$687K	–	724
2019 Q1	$687K	Sell	60,655 -20,059	-25%	-$224K	0.04%	439
2018 Q4	$700K	Buy	+80,714	New	+$926K	0.04%	333
2018 Q3	–	Sell	-34,745	Closed	-$556K	–	748
2018 Q2	$556K	Buy	+34,745	New	+$514K	0.01%	591
2017 Q3	–	Sell	-27,940	Closed	-$441K	–	762
2017 Q2	$441K	Sell	27,940 -11,940	-30%	-$173K	0.01%	626
2017 Q1	$569K	Buy	39,880 +22,567	+130%	+$309K	0.01%	604
2016 Q4	$221K	Buy	17,313 +3,343	+24%	+$42.2K	0.01%	750
2016 Q3	$185K	Sell	13,970 -72,595	-84%	-$849K	0.01%	626
2016 Q2	$948K	Buy	+86,565	New	+$846K	0.04%	435

Other funds holding IRWD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Quantitative Investment Management's IRWD Position: Q3 2021 in Review

Quantitative Investment Management sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2021, closing a stake of 22,175 shares — an estimated $285K sold.

Quantitative Investment Management first reported a position in IRWD in Q2 2016 and held it in 10 quarters. The position peaked at $948K in Q2 2016. 227 funds tracked by Wall St. Rank hold IRWD as of Q3 2021.

Quantitative Investment Management reported no remaining Ironwood Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Quantitative Investment Management sold 22,175 Ironwood Pharmaceuticals shares in Q3 2021, an estimated $285K.
Quantitative Investment Management first reported a position in Ironwood Pharmaceuticals in Q2 2016 and held it in 10 quarters.
Quantitative Investment Management's Ironwood Pharmaceuticals position peaked at $948K in Q2 2016.
227 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2021.

Based on Quantitative Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.